Substantial effects of apolipoprotein E ε4 on memory decline in very old age: longitudinal findings from a population-based sample

Neurobiol Aging. 2013 Dec;34(12):2734-9. doi: 10.1016/j.neurobiolaging.2013.06.002. Epub 2013 Jul 12.

Abstract

We examined associations between the apolipoprotein E (APOE) ε4 allele and levels of performance and rates of change in cognition in late life taking incident dementia into account. The sample consisted of 482 nondemented individuals, aged 80 years and older at baseline, drawn from the OCTO twin study. A battery of 10 cognitive tests was administered at 5 occasions with measurements intervals of 2 years. We fitted hierarchical linear models with time specified as time to death and controlled for baseline age, sex, education, stroke, cardiovascular disease, hypertension, diabetes, and incident dementia. The ε4 allele was significantly associated with lower levels of performance or steeper rate of decline in all 7 memory tests. Largest effect sizes were found in tests of delayed recall and recognition memory. The effects of the APOE ε4 allele were, however, reduced to a nonsignificant level in all tests except 1 after accounting for incident dementia. The findings support the notion that the APOE ε4 allele is associated with substantial memory decline in very old age, but as expected, the effect is largely related to incident dementia.

Keywords: APOE; Cognition; Cognitive change; Cognitive performance; Oldest old.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Aging / genetics
  • Aging / psychology
  • Alleles
  • Apolipoprotein E4 / genetics*
  • Cognition*
  • Dementia / epidemiology
  • Dementia / genetics*
  • Female
  • Humans
  • Incidence
  • Longitudinal Studies
  • Male
  • Memory Disorders / genetics*
  • Memory Disorders / psychology*
  • Memory*
  • Mental Recall
  • Neuropsychological Tests
  • Twin Studies as Topic

Substances

  • Apolipoprotein E4